Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Open-label, Randomized Study to Evaluate the Safety and Tolerability of Freeze-dried Human Rabies Vaccine (Human Diploid Cells) Administered to Participants With Different Immunization Schedules

NCT07021703 is registered in ClinicalTrials.gov with Ningbo Rongan Biological Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07021703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07021703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Open-label, Randomized Study to Evaluate the Safety and Tolerability of Freeze-dried Human Rabies Vaccine (Human Diploid Cells) Administered to Participants With Different Immunization Schedules
Lead sponsor
Ningbo Rongan Biological Pharmaceutical Co., Ltd.
Phase
Phase 1
Overall status
Recruiting
Start date
May 23, 2025
Completion date
December 31, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rabies